New inhaler powder aims to ease breathing for COPD patients
NCT ID NCT07583849
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study tests a new inhaled powder called HSK39004 for people with chronic obstructive pulmonary disease (COPD). About 376 adults aged 40 to 80 will use the inhaler or a placebo for 12 weeks to see if it improves lung function. The goal is to control the disease and make breathing easier, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.